NASDAQ:MRSN - Mersana Therapeutics, Inc.
$6.77
 $0.41
+6.45%
2:10PM EDT
2019-02-15
Mersana Therapeutics, Inc., incorporated on January 4, 2001, is a biotechnology company. The Company is focused on discovering and developing a pipeline of antibody drug conjugates (ADCs). The Company focuses on advancing a pipeline of targeted oncology therapeutics leveraging its Fleximer immunoconjugate technology. The Fleximer platform allows it to design ADCs with specific properties and manage the drug's chances of attacking cancers. Its product candidates include XMT-1522 and XMT-1536. The ADC therapies treat cancer patients by engineering a drug conjugate with various anti-cancer agents and controlling when, where and how those agents are released. Dolaflexin is its Fleximer antibody drug conjugation platform, which pairs the Fleximer polymer with its linker chemistries to create ADC therapies. XMT1522The lead product candidate, XMT1522, is a dolaflexin ADC targeting HER2expressing tumors. It is in Phase I clinical development. HER2 belongs to a family of signaling molecules that are highly and preferentially expressed on the surface of various cancer cells and are known to play a role in promoting tumor cell growth. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  MRSN     avg for
industry  
  avg for
sector  
42 stocks weight:  47. 85   0. 00   0. 00  
42 stocks rank:  2. 80 K 1. 86 K 1. 09 K
# analyst opinions:  5. 00   14. 92   14. 43  
mean recommendation:  1. 70   1. 91   1. 93  

quick ratio:  2. 76   5. 37   1. 81  
current ratio:  2. 86   5. 69   2. 19  

target price low:  10. 00   88. 97   117. 82  
target price avg:  13. 00   115. 19   141. 96  
target price high:  15. 00   143. 40   163. 16  
1-yr high:  22. 68   124. 30   142. 77  
last close:  6. 36   101. 85   127. 84  
50-day avg:  4. 62   98. 27   122. 46  
200-day avg:  10. 82   99. 72   122. 70  
1-yr low:  3. 45   78. 19   100. 16  
volume:  136. 65 K 2. 38 M 4. 64 M
50-day avg volume:  122. 76 K 3. 31 M 4. 94 M
200-day avg volume:  141. 32 K 3. 23 M 4. 28 M

1-day return:  0. 16 % 0. 22 % 0. 48 %
this week return:  18. 66 % 1. 77 % 2. 01 %
12-wk return:  16. 70 % 6. 56 % 3. 33 %
52-wk return:  -58. 11 % -2. 23 % 14. 35 %

enterprise value (EV):  55. 59 M 55. 17 B 104. 51 B
market cap:  147. 44 M 49. 01 B 96. 46 B
EBITDA:  -56. 06 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -0. 99   -91. 79   2. 29  
enterprise/revenue (EV/R):  4. 39   29. 84   23. 39  
total revenue:  12. 67 M 11. 28 B 40. 22 B
total debt:  0. 00   13. 73 B 16. 57 B
net income (common):  -55. 79 M 2. 37 B 3. 58 B

shares outstanding:  23. 18 M 607. 99 M 1. 22 B
shares:  9. 71 M 605. 53 M 1. 15 B
shares short:  589. 49 K 11. 62 M 12. 55 M
shares short prior month:  1. 22 M 11. 95 M 13. 44 M
short ratio:  5. 10   4. 82   3. 10  
short % of float:  4. 87 % 6. 19 % 2. 82 %
total cash/share:  3. 71   12. 02   11. 46  
total cash:  86. 06 M 7. 41 B 7. 37 B
free cash flow:  -26. 93 M 95. 99 M 2. 04 B
operating cash flow:  -50. 31 M 164. 74 M 3. 04 B

book value:  1. 29   14. 43   28. 26  
price/book:  4. 93   -1. 57   -2. 97  
gross profits:  -29. 16 M 8. 28 B 18. 09 B
operating margins:  -451. 79 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  0. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  -31. 59 % --- ---
1-yr mean volatility:  -0. 18 % 0. 01 % 0. 06 %

1-yr EPS:  -2. 43   3. 03   4. 09  
forward EPS:  -2. 45   4. 33   6. 99  
P/E:  -2. 62   6. 11   26. 91  
forward P/E:  -2. 60   8. 38   10. 48  
PE/G:  0. 04   0. 37   5. 61  
growth:  -65. 70 % 683. 72 % 104. 79 %
earnings high:  -0. 65   1. 27   1. 66  
earnings avg:  -0. 69   1. 01   1. 53  
earnings low:  -0. 75   0. 76   1. 40  
revenue high:  5. 00 M 2. 86 B 11. 19 B
revenue avg:  3. 92 M 2. 78 B 10. 84 B
revenue low:  3. 00 M 2. 67 B 10. 64 B
return on assets:  -30. 14 % -3. 27 % 3. 81 %
return on equity:  -98. 31 % 107. 48 % 27. 82 %
revenue growth:  -65. 70 % 648. 36 % 97. 70 %
revenue/share:  0. 55   14. 68   59. 83  

beta (1yr vs S&P500):  1. 77   1. 21   0. 93  
sharpe (1yr):  -0. 50   0. 06   0. 98  


Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : MRSN
.    + 0.091 =         0.091 :: INITIAL WEIGHT
.  + 549.075 =       549.165 :: inverse volume-to-price addition
.  + 200.789 =       749.955 :: spline projection addition
.  - 199.272 =       550.682 :: poor performance penalty
.    x 0.646 =       356.006 :: one-year gains+dividend factor
.    x 9.115 =       3244.85 :: 13 weeks' performance factor
.    x 1.492 =      4842.903 :: industry recommendation factor
.    x 2.505 =     12132.392 :: symbol recommendation factor
.    x 1.147 =      13917.12 :: EV/R factor
.    x 0.997 =     13875.169 :: return on assets factor
.     x 0.99 =     13738.755 :: return on equity factor
.    x 0.993 =     13648.491 :: revenue growth factor
.    x 2.503 =     34162.501 :: current ratio factor
.    x 1.253 =     42798.348 :: quick ratio factor
.    x 1.094 =     46806.572 :: short ratio factor
.    x 2.049 =     95922.608 :: price-to-book factor
.    x 1.297 =    124420.182 :: 5-day avg > 50-day avg
.     x 2.16 =    268800.574 :: P/E weight
.    x 2.209 =    593769.478 :: PE/G factor
.    x 1.441 =    855382.967 :: beta factor
.    x 0.499 =     427028.63 :: sharpe factor
.    x 1.818 =    776398.491 :: target low factor
.    x 1.341 =   1040833.474 :: target mean factor
.    x 1.117 =   1162147.095 :: target high factor
.    x 1.066 =   1238398.827 :: industry 12-weeks return
.    x 0.963 =   1192788.935 :: "drift" penalty 2 days ago
.    x 0.995 =   1187409.915 :: "drift" penalty 3 days ago
.      x 1.0 =   1186990.916 :: overall "drift" factor
.    x 0.999 =   1185421.916 :: largest single-day jump factor
.    x 0.092 =    109558.403 :: low price factor
.      x 1.0 =    109565.756 :: factor hist industry gain for week 06
.   cubeRoot =        47.851 :: reduced for readability
.                     47.851 :: FINAL WEIGHT for NASDAQ:MRSN


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org